Today, our ThermaCare? acquisition is fully operational.

Today, I am excited to share that the acquisition of ThermaCare? is fully operational. I would like to warmly and officially welcome new 120 new colleagues from US, Germany and Spain! At Angelini Pharma we are now a bigger family and I can’t wait to meet all our associates.

Why ThermaCare? - Strengthening our leading position in CH with a distinctive brand

Angelini Pharma aims at focusing its efforts, both organically and inorganically, in selected segments ie Mental Health (incl. Pain), Rare Diseases and Consumer Health. The acquisition of ThermaCare is aligned with our ambition to strengthen our leadership in CH and to further grow in Europe thanks to this distinctive brand.

The brand Thermacare?

Thermacare? is the only muscle & joint trusted brand with a long-standing heritage that delivers effective relief with soothing comfort to pain through the power of real heat. It is also a leading international brand in the topical analgesics market segment.

What Thermacare? brings to Angelini Pharma

The ThermaCare? deal includes the global business rights (excluding North America), all the intellectual property rights to the existing and ongoing R&D projects and the dedicated US manufacturing site in Albany, Georgia. The Albany plant carries a huge symbolic value as well, as it represents the expansion of our current industrial footprint beyond Italy.

What Angelini brings to Thermacare?

We are fully committed to capture the untapped ThermaCare? potential and will invest significantly more to fuel the brand growth in all current geographies with new launches while also assessing the opportunity to expand it in new territories. We are in for the long term deploying a ten-years brand strategy by leveraging our expertise in CH products life-cycle management. Moreover, we will exploit the proven efficacy of ThermaCare? products based on the supporting scientific evidences.

A new affiliate in Europe

The acquisition of ThermaCare? allows us to open a new affiliate in Germany which makes us all proud. The offices will be in Munich and we are, as we speak, building up the team to be fully in place by June.

We are getting ready and we are fully committed to make it a success. As the old say goes: When the going is tough, the tough gets going. In Angelini Pharma we are all very passionate, determined and resilient. Together, we will overcome this period.

In the photo, you find Sergio Marullo di Condojanni, Antonio Mazzeo, Enza Onnis, Fabio De Luca and I.